Goldman Sachs’s Shockwave Medical SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-179,235
Closed -$58.4M – 6023
2024
Q1
$58.4M Buy
179,235
+33,780
+23% +$8.29M 0.01% 1066
2023
Q4
$27.7M Sell
145,455
-6,540
-4% -$1.24M 0.01% 1614
2023
Q3
$30.3M Sell
151,995
-48,605
-24% -$11.5M 0.01% 1450
2023
Q2
$57.3M Sell
200,600
-40,667
-17% -$11.3M 0.01% 1003
2023
Q1
$52.3M Sell
241,267
-64,531
-21% -$12.6M 0.01% 1046
2022
Q4
$62.9M Sell
305,798
-139,874
-31% -$35.4M 0.02% 989
2022
Q3
$124M Buy
445,672
+187,923
+73% +$47.8M 0.03% 581
2022
Q2
$49.3M Sell
257,749
-30,796
-11% -$5.44M 0.01% 1130
2022
Q1
$59.8M Buy
288,545
+45,542
+19% +$7.51M 0.01% 1138
2021
Q4
$43.3M Buy
243,003
+27,085
+13% +$5.34M 0.01% 1464
2021
Q3
$44.5M Buy
215,918
+9,503
+5% +$1.87M 0.01% 1361
2021
Q2
$39.2M Buy
206,415
+113,447
+122% +$18.6M 0.01% 1471
2021
Q1
$12.1M Sell
92,968
-90,716
-49% -$10.9M ﹤0.01% 2393
2020
Q4
$19.1M Sell
183,684
-17,007
-8% -$1.47M ﹤0.01% 1896
2020
Q3
$15.2M Sell
200,691
-9,847
-5% -$558K ﹤0.01% 1964
2020
Q2
$10M Buy
210,538
+177,916
+545% +$7.33M ﹤0.01% 2276
2020
Q1
$1.08M Buy
32,622
+11,740
+56% +$466K ﹤0.01% 3695
2019
Q4
$917K Sell
20,882
-31,555
-60% -$1.17M ﹤0.01% 4181
2019
Q3
$1.57M Buy
52,437
+2,019
+4% +$85.7K ﹤0.01% 3706
2019
Q2
$2.88M Sell
50,418
-75,646
-60% -$3.67M ﹤0.01% 3273
2019
Q1
$4.22M Buy
+126,064
New +$4.19M ﹤0.01% 3107

Other funds holding SWAV

Goldman Sachs's SWAV Position: Q2 2024 in Review

Goldman Sachs sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 179,235 shares — an estimated $58.4M sold.

Goldman Sachs first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $124M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Goldman Sachs reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 179,235 Shockwave Medical shares in Q2 2024, an estimated $58.4M.
  • Goldman Sachs first reported a position in Shockwave Medical in Q1 2019 and held it in 21 quarters.
  • Goldman Sachs's Shockwave Medical position peaked at $124M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.